- Home
- CMPX vs FBLG Comparison
CMPX vs FBLG Comparison
Compare CMPX & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- FBLG
- Stock Information
- Founded
- CMPX 2014
- FBLG 2021
- Country
- CMPX United States
- FBLG United States
- Employees
- CMPX N/A
- FBLG N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- FBLG
- Sector
- CMPX Health Care
- FBLG
- Exchange
- CMPX Nasdaq
- FBLG NYSE
- Market Cap
- CMPX 291.8M
- FBLG 37.1M
- IPO Year
- CMPX N/A
- FBLG 2024
- Fundamental
- Price
- CMPX $2.88
- FBLG $0.63
- Analyst Decision
- CMPX Strong Buy
- FBLG Strong Buy
- Analyst Count
- CMPX 9
- FBLG 4
- Target Price
- CMPX $12.67
- FBLG $13.00
- AVG Volume (30 Days)
- CMPX 816.0K
- FBLG 535.0K
- Earning Date
- CMPX 08-11-2025
- FBLG 08-06-2025
- Dividend Yield
- CMPX N/A
- FBLG N/A
- EPS Growth
- CMPX N/A
- FBLG N/A
- EPS
- CMPX N/A
- FBLG N/A
- Revenue
- CMPX $850,000.00
- FBLG N/A
- Revenue This Year
- CMPX N/A
- FBLG N/A
- Revenue Next Year
- CMPX N/A
- FBLG N/A
- P/E Ratio
- CMPX N/A
- FBLG N/A
- Revenue Growth
- CMPX N/A
- FBLG N/A
- 52 Week Low
- CMPX $0.87
- FBLG $0.58
- 52 Week High
- CMPX $4.08
- FBLG $5.62
- Technical
- Relative Strength Index (RSI)
- CMPX 64.52
- FBLG 37.68
- Support Level
- CMPX $2.62
- FBLG $0.58
- Resistance Level
- CMPX $2.87
- FBLG $0.67
- Average True Range (ATR)
- CMPX 0.16
- FBLG 0.06
- MACD
- CMPX 0.00
- FBLG 0.00
- Stochastic Oscillator
- CMPX 81.03
- FBLG 24.11
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.